Recent Progress in Prediction Systems for Drug-induced Liver Injury Using In vitro Cell Culture

Area of Science:

• Hepatology
• Toxicology
• Immunology

Background:

• Drug-induced liver injury (DILI) is a significant challenge in drug development, necessitating reliable predictive assays.
• Understanding the interplay between metabolic activation and immune responses is key to predicting DILI.
• Current in vitro methods aim to replicate these complex biological processes.

Purpose of the Study:

• To review advancements in in vitro assays for identifying potential DILI-causing drugs and xenobiotics.
• To conduct a mechanistic study on DILI using cell culture systems.
• To evaluate the limitations of current in vitro cell culture systems in DILI research.

Main Methods:

• A literature search of the PubMed database was conducted to gather information on DILI.
• Analysis of cellular and immunological mechanisms underlying DILI.
• Evaluation of various in vitro cell culture systems, including co-cultures and spheroids.

Main Results:

• DILI initiation involves drug metabolic activation, protein adduct formation, and subsequent immune reactions mediated by T lymphocytes.
• Cellular-based in vitro systems, comprising hepatocytes and immune cells, have been developed to model DILI.
• These systems demonstrate moderate sensitivity (approx. 50%) and high specificity (approx. 90%) in identifying DILI-inducing drugs.

Conclusions:

• Co-culture systems incorporating human hepatocyte-derived cells and immune/inflammatory cells are effective in identifying DILI-causing drugs.
• These advanced in vitro models elucidate the mechanisms of action involved in DILI.
• Continued development of in vitro systems is vital for improving drug safety assessment and preventing DILI.